Bharat Immunologicals & Biologicals Corporation Limited announced earnings results for the second quarter ended September 30, 2020. For the second quarter, the company announced total revenue was INR 254.958 million compared to INR 82.758 million a year ago. Net loss was INR 38.662 million compared to INR 56.591 million a year ago. Basic loss per share from continuing operations was INR 0.9 compared to INR 1.28 a year ago. For the half year, total revenue was INR 440.67 million. Net loss was INR 46.507 million. Basic loss per share from continuing operations was INR 1.08.